LumiraDx Limited
LMDXNASDAQHealthcare
$0.02
+$0.00(+0.00%)
Market Cap$5102097
P/E Ratio—
52W High$0.0282
52W Low$0.0151
LumiraDx Limited (LMDX) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
LMDX · earnings · updated Jun 9, 2026
Latest Earnings
Q4 FY2023Report Date: Nov 8, 2023EPS Actual
-$0.47
Est. -$0.11 · -327.3%
Revenue
—
Est. $0.02B
Fiscal Period
Q4 FY2023
FY ends December
Report Date
Nov 8, 2023
After Market Close
▼ Miss EPS
LMDX reports quarterly as a NASDAQ-listed Medical - Diagnostics & Research company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2024 | Aug 22, 2024 | — | — | — | — | — | — |
| ◌ Q2 FY2024 | May 14, 2024 | — | — | — | — | — | — |
| ◌ Q1 FY2024 | Mar 19, 2024 | -$0.06 | — | — | — | $0.02B | — |
| ▼ Q4 FY2023 | Nov 8, 2023 | -$0.11 | -$0.47 | -327.3% | — | $0.02B | — |
| ▼ Q3 FY2023 | Aug 24, 2023 | -$0.15 | -$0.16 | -6.7% | $0.02B | — | — |
| ▲ Q2 FY2023 | May 16, 2023 | -$0.15 | -$0.14 | +6.7% | $0.02B | — | — |
| ▼ Q1 FY2023 | Mar 21, 2023 | -$0.19 | -$0.32 | -68.4% | $0.04B | $0.04B | -1.5% |
| ▼ Q4 FY2022 | Nov 9, 2022 | -$0.30 | -$0.47 | -56.7% | $0.04B | — | — |
Q3 FY2024
Aug 22, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2024
May 14, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2024
Mar 19, 2024
EPS Actual
—
EPS Est.
-$0.06
EPS Surpr.
—
Revenue
—
Q4 FY2023
Nov 8, 2023Miss
EPS Actual
-$0.47
EPS Est.
-$0.11
EPS Surpr.
-327.3%
Revenue
—
Q3 FY2023
Aug 24, 2023Miss
EPS Actual
-$0.16
EPS Est.
-$0.15
EPS Surpr.
-6.7%
Revenue
$0.02B
Q2 FY2023
May 16, 2023Beat
EPS Actual
-$0.14
EPS Est.
-$0.15
EPS Surpr.
+6.7%
Revenue
$0.02B
Q1 FY2023
Mar 21, 2023Miss
EPS Actual
-$0.32
EPS Est.
-$0.19
EPS Surpr.
-68.4%
Revenue
$0.04B
Q4 FY2022
Nov 9, 2022Miss
EPS Actual
-$0.47
EPS Est.
-$0.30
EPS Surpr.
-56.7%
Revenue
$0.04B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $1.54 | $1.54 | $1.54 | 1 |
| Q2 FY2024 | $1.34 | $1.34 | $1.34 | 1 |
| Q1 FY2024 | $1.57 | $1.57 | $1.57 | 1 |
| Q4 FY2023 | $-0.06 | $-0.06 | $-0.06 | 1 |
| Q3 FY2023 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2023 | $1.19 | $1.19 | $1.19 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q4 FY2023 | Nov 8, 2023 | -327.3% | $0.10 | $0.09 | -1.99% |
| ▼ Q3 FY2023 | Aug 24, 2023 | -6.7% | $0.41 | $0.40 | -1.72% |
| ▲ Q2 FY2023 | May 16, 2023 | +6.7% | $0.54 | $0.51 | -4.75% |
| ▼ Q1 FY2023 | Mar 21, 2023 | -68.4% | $0.86 | $0.86 | -0.06% |
| ▼ Q4 FY2022 | Nov 9, 2022 | -56.7% | $1.00 | $1.10 | +10.10% |
| ▼ Q3 FY2022 | Aug 18, 2022 | -123.1% | $1.50 | $1.20 | -20.00% |
| ▼ Q2 FY2022 | May 11, 2022 | -266.7% | $3.86 | $3.80 | -1.55% |
| ▼ Q1 FY2022 | Mar 10, 2022 | -14.3% | $6.16 | $6.08 | -1.30% |
Q4 FY2023-1.99%
Report Date
Nov 8, 2023
EPS Beat/Miss
-327.3%
Price Before
$0.10
Price After
$0.09
Q3 FY2023-1.72%
Report Date
Aug 24, 2023
EPS Beat/Miss
-6.7%
Price Before
$0.41
Price After
$0.40
Q2 FY2023-4.75%
Report Date
May 16, 2023
EPS Beat/Miss
+6.7%
Price Before
$0.54
Price After
$0.51
Q1 FY2023-0.06%
Report Date
Mar 21, 2023
EPS Beat/Miss
-68.4%
Price Before
$0.86
Price After
$0.86
Q4 FY2022+10.10%
Report Date
Nov 9, 2022
EPS Beat/Miss
-56.7%
Price Before
$1.00
Price After
$1.10
Q3 FY2022-20.00%
Report Date
Aug 18, 2022
EPS Beat/Miss
-123.1%
Price Before
$1.50
Price After
$1.20
Q2 FY2022-1.55%
Report Date
May 11, 2022
EPS Beat/Miss
-266.7%
Price Before
$3.86
Price After
$3.80
Q1 FY2022-1.30%
Report Date
Mar 10, 2022
EPS Beat/Miss
-14.3%
Price Before
$6.16
Price After
$6.08
Avg Beat Reaction-4.75%
Avg Miss Reaction-2.36%
Beat Rate1 / 8 quarters
Largest Move-20.00% (Q3 FY2022)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: LMDX ends December
LumiraDx Limited (LMDX) most recently reported earnings on November 8, 2023 for Q4 FY2023, posting EPS of $-0.47 — missing the analyst consensus of $-0.11 by -327.3%. The next LMDX earnings date is expected around September 1, 2026.
Each quarter, investors track LMDX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. LMDX revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
LMDX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
LMDX earnings · 5 questionsLumiraDx Limited's next earnings report is expected around September 1, 2026. LMDX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; LMDX historically reports after market close (AMC).
LMDX earnings datewhen is LMDX earningsLMDX next earnings datewhen does LMDX report earningsLMDX earnings calendar
▸ Source: FMP · LumiraDx Limited SEC filings · US GAAP · LumiraDx Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026